Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

 Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

Insights+: COVID-19 Healthcare News Monthly Updates – November 2020

  • Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it
  • Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease
  • PharmaShots is keeping a track of all of the important updates in the Life-sciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date

1.Moderna Announces Amendment to Current Supply Agreement with United Kingdom Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)

Nov 29, 2020 | Collaboration

2. Colchicine Shows Promise as a Treatment for At-Home COVID-19 Patients — Recruitment of Participants in the COLCORONA P-III Study Likely to End in 2020

Nov 28, 2020 | Clinical Trial

3. BASE10 and DNA Link Partners on Research to Support Authorization of Antibody Test at the Point of Care

Nov 26, 2020 | Clinical Trial

4. Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

Nov 25, 2020 | Regulatory

5. Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies 

Nov 25, 2020 | Regulatory 

6. CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients 

Nov 25, 2020 | Clinical Trial 

7. NeuroRx and Relief Announce Initial Successful Rsults from Expanded Access Use of RLF-100 (aviptadil) in Patients with Critical COVID-19 and Severe Comorbidity: 72% survival seen in ICU patients 

Nov 24, 2020 | Clinical Trial 

8. Vivacelle Bio Receives $5.3 Million Award from the US Navy for a Clinical Trial of VBI-S for Treatment of Hypovolemia of Septic Shock Due to COVID or other Pathogens 

Nov 24, 2020 | Grant 

9. ReiThera Announces its GRAd-COV2 COVID-19 Vaccine Candidate is Well Tolerated and Induces Clear Immune Responses in Healthy Subjects Aged 18-55 Years 

Nov 24, 2020 | Clinical Trial 

10. Longitude Prize Launches AMR Voices: Stories from the frontlines of antibiotic resistance during Covid-19 

Nov 24, 2020 | Launch 

11. Arizona BioTech Company Successfully Completes Pre-Clinical Testing for Vaccine Alternative to Prevent COVID-19 Infection, Ready for Human Trials 

Nov 23, 2020 | Clinical Trial 

12. FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 

Nov 21, 2020 | Regulatory 

13. Regeneron’s REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization 

Nov 21, 2020 | Regulatory 

14. Lilly’s Neutralizing Antibody bBmlanivimab (LY-CoV555) Receives Interim Authorization from Health Canada as a Treatment for COVID-19 

Nov 20, 2020 | Regulatory 

15. Persavita is Preparing for a Clinical Trial to Test its Experimental Natural Health Product in Covid-19 

Nov 20, 2020 | Clinical Trial 

16. FDA Grants Emergency Use Authorisation for Baricitinib in Hospitalised COVID-19 Patients Nine Months After Initial Hypothesis was Published by BenevolentAI 

Nov 20, 2020 | Regulatory 

17. Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development 

Nov 20, 2020 | Clinical Trial 

18. Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19 

Nov 19, 2020 | Regulatory 

19. Icahn School of Medicine at Mount Sinai and Boehringer Ingelheim Collaborate on First Study to Evaluate Nintedanib in Patients with Fibrosing ILD following COVID-19 Infection 

Nov 19, 2020 | Collaboration 

20. RedHill Announces Unanimous DSMB Recommendation to Continue Phase 2/3 COVID-19 Study with Opaganib 

Nov 19, 2020 | Regulatory 

21. India’s Indigenous Solution to COVID-19 in Progress 

Nov 19, 2020 |  Pharma

22. In the lab, St. Jude Scientists Identify Possible COVID-19 Treatment 

Nov 18, 2020 |  Pharma

23. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers 

Nov 18, 2020 | Collaboration 

24. BioLineRx Announces Initiation of Phase 1b Clinical Trial in Patients with Acute Respiratory Distress Syndrome (ARDS) Secondary to COVID-19 and Other Respiratory Viral Infections 

Nov 18, 2020 | Clinical Trial 

25. Diabetes, Hypertension May Increase Risk of COVID-19 Brain Complications 

Nov 18, 2020 |  Pharma

26. FDA Authorizes First COVID-19 Test for Self-Testing at Home 

Nov 17, 2020 | Diagnostic 

27. Ampio’s Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress 

Nov 17, 2020 | Clinical Trial 

28. RedHill Biopharma’s Second COVID-19 Candidate, RHB-107, Cleared by FDA for Phase 2/3 Study in Symptomatic COVID-19 Disease 

Nov 17, 2020 | Clinical Trial 

29. Samsung Biologics Announces Strategic Manufacturing Partnership with Lilly to Accelerate Delivery of COVID-19 Antibody Treatments 

Nov 17, 2020 | Collaboration 

30. TrippBio Reports Positive Results from Investigator-Initiated Clinical Trial of TD213 for the Treatment of Mild to Moderate COVID-19 Infections 

Nov 16, 2020 | Clinical Trial 

31. RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase 2 Study with Opaganib – Data Expected in the Coming Weeks 

Nov 16, 2020 | Clinical Trial 

32. INOVIO Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical Trial for its COVID-19 DNA Vaccine Candidate, INO-4800; Trial Will Be Funded by the U.S. Department of Defense 

Nov 16, 2020 | Clinical Trial 

33. Biological E. Limited Starts Phase I/II Clinical Trial of its COVID-19 Vaccine Candidate 

Nov 16, 2020 | Clinical Trial 

34Johnson & Johnson and U.S. Department of Health & Human Services Expand Agreement to Support Next Phase of COVID-19 Vaccine Candidate Research and Development 

Nov 14, 2020 | Collaboration 

35. NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100 for Critical COVID-19 with Respiratory Failure 

Nov 13, 2020 | Clinical Trial 

36. Medicago and GSK announce start of Phase 2/3 clinical trials of adjuvanted COVID-19 vaccine candidate 

Nov 12, 2020 | Clinical Trial 

37. AstraZeneca Partners with CCT to Conduct COVID-19 Vaccine Clinical Trials in Arizona 

Nov 12, 2020 | Collaboration 

38. Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies 

Nov 11, 2020 | Collaboration 

39. NYU Langone Health to Enroll Healthy Volunteers In Clinical Trial for COVID-19 Vaccine 

Nov 11, 2020 | Clinical Trial 

40. ADVAITE’s High Complexity CLIA Lab Receives Authorization from Yale University to Offer Highly Accurate COVID-19 SalivaDirect™ Test 

Nov 11, 2020 | Regulatory 

41. Sagent Pharmaceuticals Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 Treatment 

Nov 11, 2020 | Clinical Trial 

42. Mountain Valley MD Files Patent to Protect Science Achievement in Solubilization of ivermectin Without Organic Solvents and Its Application to COVID-19 and Other Therapies 

Nov 11, 2020 | Regulatory 

43. The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy 

Nov 11, 2020 | Clinical Trial 

44. Co-Diagnostics Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction 

Nov 11, 2020 |  Clinical Trial 

45. Ampio’s Phase I Study For Inhaled Ampion Advances To 2nd Group Of COVID-19 Patients With Respiratory Distress 

Nov 10, 2020 | Clinical Trial 

46. CollPlant Announces Early Development Program of Antiviral Agent for Potential Treatment of COVID-19 Patients 

Nov 10, 2020 |  Clinical Trial 

47. New Research Published in The Lancet Psychiatry Finds COVID-19 Associated with Increased Risk for Developing Psychiatric Disorders 

Nov 9, 2020 |  Clinical Trial

48. New COVID Vaccine Clinical Trials Enrolling At Local Lake Charles Research Site 

Nov 9, 2020 | Clinical Trial 

49. CARE GA Receives Study May Proceed Letter from US FDA to Initiate Phase II Clinical Trial of Senhwa’s Silmitasertib in COVID-19 Patients 

Nov 6, 2020 | Clinical Trial 

50. NeuroRx and Relief Therapeutics Announce Continuation of RLF-100 trial for Treatment of COVID-19 Respiratory Failure: Trial is on Track to Complete Enrollment in 2020 

Nov 5, 2020 | Clinical Trial 

51. New Research Study Validates Performance and Accuracy of Truvian Sciences’ Easy Check COVID-19 IgM/IgG Test 

Nov 3, 2020 | Regulatory 

52. Senhwa Announces Multiple IND application submissions to US FDA for Silmitasertib as a Potential Treatment for COVID-19 

Nov 2, 2020 | Regulatory 

53. Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine 

Nov 2, 2020 |  Clinical Trial 

54. RevImmune Advances New Immunotherapy in COVID-19 

Nov 2, 2020 |  Clinical Trial 

55. Immunic, Inc. Announces 200 Patients Enrolled in Its Phase 2 CALVID-1 Trial of IMU-838 for the Treatment of Moderate COVID-19, Allowing for Main Phase 2 Efficacy Analysis to Proceed 

Nov 2, 2020 | Clinical Trial 

Related Post: Insights+: COVID-19 Healthcare News Monthly Updates – October 2020

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post